| 注册
首页|期刊导航|中医学报|中医药治疗非小细胞肺癌研究进展

中医药治疗非小细胞肺癌研究进展

何桂馨 葛婷 赵平 李文涛 王双翠 于建春

中医学报2026,Vol.41Issue(5):938-946,9.
中医学报2026,Vol.41Issue(5):938-946,9.DOI:10.16368/j.issn.1674-8999.2026.05.137

中医药治疗非小细胞肺癌研究进展

Research Progress on Traditional Chinese Medicine Treatment of Non-Small Cell Lung Cancer

何桂馨 1葛婷 1赵平 2李文涛 3王双翠 1于建春4

作者信息

  • 1. 天津中医药大学第一附属医院,天津 300381||国家中医针灸临床医学研究中心,天津 300381||天津中医药大学第一附属医院医学实验中心,天津 300381||天津中医药大学研究生院,天津 301617
  • 2. 常熟市中医院(新区医院)中医科,江苏 常熟 215500
  • 3. 天津中医药大学第一附属医院,天津 300381||国家中医针灸临床医学研究中心,天津 300381
  • 4. 天津中医药大学第一附属医院,天津 300381||国家中医针灸临床医学研究中心,天津 300381||天津中医药大学第一附属医院医学实验中心,天津 300381
  • 折叠

摘要

Abstract

T cells affect tumor survival,metastasis,and drug resistance through interactions with other immune cells,and are involved in immune evasion mechanisms.Traditional Chinese medicine(TCM)shows unique advantages in regulating T cell function and improving the immune function of patients with non-small cell lung cancer(NSCLC).By modulating the infiltration,activity,and proportion of T cells,TCM provides new possibilities for the treatment of NSCLC.However,current research still has some limitations.Although clinical studies have shown that TCM formulas,monomers,or acupuncture can regulate T cell subsets,most are combined with Western medical treatments.Studies using only Chinese herbal medicine or traditional formulas as controls are still insufficient.Moreover,clinical re-search is mostly limited to analyzing T cells in patients' peripheral blood and has not deeply investigated the related molecular mecha-nisms.In addition,there may be significant differences in TCM formulations,dosages,and preparation methods,which can introduce cer-tain biases in efficacy observation.At the same time,most studies focus on short-term efficacy,with limited data on long-term follow-up and safety evaluation,lacking scientific evidence based on evidence-based medicine.In basic research,the use of TCM to treat NSCLC via T cell subsets is still in its early stages,and the related molecular mechanisms are not yet clear.In the future,research should focus on how TCM regulates T cell subsets to combat NSCLC,identify more effective therapeutic targets,and provide a solid sci-entific basis for clinical applications.

关键词

非小细胞肺癌/中医药/T 细胞/免疫细胞

Key words

non-small cell lung cancer/traditional Chinese medicine/T cell/immune cell

分类

医药卫生

引用本文复制引用

何桂馨,葛婷,赵平,李文涛,王双翠,于建春..中医药治疗非小细胞肺癌研究进展[J].中医学报,2026,41(5):938-946,9.

基金项目

苏州市科技发展计划项目(SKYD2023063) (SKYD2023063)

常熟市科技发展计划项目(CSWS202211) (CSWS202211)

国家中医针灸临床医学研究中心开放课题项目(NCRCOP2024018) (NCRCOP2024018)

中医学报

1674-8999

访问量0
|
下载量0
段落导航相关论文